Corel Medical Series: Cancer/Corel Medical Series: Cancer.iso/mac/Program/Indexdat/indexc.I

Text File | 1997-01-27 | 4KB | 2 lines

Ibuprofen,p19.9,Idarubicin,c18.17;c18.19,Ifosfamide,16,lleitis,c11a.4,lleostomy,p21.5,Ileum,p21.3,Imaging techniques,p02.11,Immature teratoma,c30.1;c30.12,Immune disorders,c41.2,Immune-enhancing therapies unproven,p13.9,Immune globulin,p20.7,Immune response,p08.3;p08.4,Immune system,4,Immunohistochemistry,c07.8,Immunosuppressors,p01.7,Implants,p06.12;REC.1,Impotence,p23.5;p23.7;c35.35,Incontinence,p26.9;c35.35,Incontinence clothing,p26.5,Independence loss of,p16.13,Infection,12,Inflammatory bowel disease,c38.3,Influenza vaccine,p20.9,Informed consent,p04.13,Infusion,7,Injection self-administered,p26.13,Insulinoma,c15.2;c15.5;c15.12,Intercourse,2,Interferon (alpha beta gamma),20,Interleukin (IL-2 IL-3 IL-6),9,International Federation of Gynecology and Obstetrics (FIGO),c09.11;c30.7;c44.8;c46.7;c47.7,Internist,p03.4,Interstitial hyperthermia,p10.7,Interstitial radiation therapy,p06.12,Intestinal parasites,c03.3,Intestinal polyposis,c36.4,Intimidation,p03.16,Intra-arterial drug delivery,p07.12,Intra-operative radiation therapy (IORT),p06.9,Intracavitary radiation therapy,p06.13,Intraductal adenocarcinoma,c35.32,Intraluminal radiation therapy,p06.13,Intraperitoneal drug delivery,p07.12,Intraspinal drug administration,p19.13,Intravenous feedings,p18.11,Intravenous infusion,p19.13,Iodine radioactive,p06.11;p08.15;c01.16;c42.15;c42.26,Iodine abundance,c42.5,Iodine deficiency,c42.5,Iometrexol,p35.8,Iridium,c02.11;c09.19;c12.19;c35.22,Irinotecan,p35.9,Islet cell carcinoma,11,Isocal,p18.12,Isolation,p16.15;p30.4,
for bone and soft tissue sarcomas,c36.11;c36.18,for cervical cancer,c09.21,for Ewing's sarcoma,c10d.11,for lung cancer,c20.18,for Iymphoma,c24.20,for osteogenic sarcoma,c10d.8,for ovarian cancer,c29.20;c30.11;c30.16,for rhabdomyosarcoma,c10d.4,for small intestine cancer,c38.12,for stomach cancer,c39.24,for testis cancer,c40.17,for trophoblastic disease,c43.16,for uterine cancer,c44.20;c44.21;c45.14;c45.17,for vaginal cancer ,c46.12,for vulvar cancer,c47.15,side effects,chr.p17.13,how it works,p08.3;p08.4,and Kaposi's sarcoma,c16.1,role in cancer,p01.8;p04.5;p08.19,suppressed,p20.2;c09.5,avoiding,p20.9,and chemotherapy ,p07.23,defenses against,p20.10,diagnosis,p20.6,from blood transfusion,p14.3,from bone marrow transplant,p12.11,from multiple myeloma,c28.17,mouth,p17.16;p17.18,post-operative,p05.18,symptoms,p20.5,treatment,p20.7,types,p20.3;p20.4,intra-arterial,p07.12,intraperitoneal,p07.12,intravenous,p05.8;p07.9,surgical implant,p05.8,via catheter,p05.9;p05.7;p07.10,via port,p05.8;p05.7;p07.11,via pump,p05.11;p19.13,anal,c02.3,painful,p23.3;p23.9,for bladder cancer,c04.18,for childhood cancers,c10a.15,for colorectal cancer,c11b.3;c11b.13;c11b.20;c11b.24;c11c.14;c11c.15,for esophageal cancer,c12.21,for gastrointestinal tract cancer,c08.9,for islet cell carcinoma,c15.10;c15.12,for Kaposi's sarcoma,c16.18,for kidney cancer,c17.10;c17.18,for leukemia,c18.23;c18.28,for lymphoma,c24.17,for melanoma,c25.16,for multiple myeloma,c28.13,for ovarian cancer,c29.20,for pancreatic cancer,c31.11,for skin cancer,c37.18,for stomach cancer,c39.16,for venereal warts,c33.12,in biological therapy,p08.7,in drug combinations,p35.14,side effects,p08.17,for bladder cancer,c04.18,for childhood cancers,c10a.15,for colorectal cancer,c11c.15,for Kaposi's sarcoma,c16.3;c16.18,for kidney cancer,c17.11,for melanoma,c25.16;c25.19,for ovarian cancer,c29.20,in biological therapy,p08.8;p08.20,side effects,p08.17,causes,c15.2,diagnosis,c15.7,questions to ask,c15.17,recurrence,c15.16,risk factors,c15.3,screening,c15.4,spread,c15.2,staging,c15.9,symptoms,c15.5,treatment,c15.10,types,c15.2,